venBio Global Strategic Fund IV, L.P.
5 of 7 shown
The 5 most recent of 7 visible filings, newest first.
- Attovia Therapeutics, Inc. 10% owner6,179,219 sharesConversion
- Attovia Therapeutics, Inc. 10% owner7,636,362 sharesConversion
- Attovia Therapeutics, Inc. 10% owner21,477,273 sharesConversion
- Attovia Therapeutics, Inc. 10% owner$6,499,984Open-market buy
- Attovia Therapeutics, Inc. 10% owner—Conversion